title: [The protocol for multi organ donor management].
abstract: Identification and preparation of a potential organ donor requires careful and meticulous intensive care, so that the organs may be harvested in the best possible condition for transplantation. The protocol consists of three key elements: (1) monitoring and haemodynamicstabilisation, (2) hormonal therapy, and (3) adequate mechanical ventilation and nosocomial pneumonia prophylaxis. Standard haemodynamic monitoring should consist of a 12 lead EGG, and direct monitoring of arterial and central venous pressures. Pulmonary artery catheterisation is indicated in donors with a left ventricular ejection fraction (LVEF) below 45%. PCWP should be kept at around 12 mm Hg, Cl at greater than 2.4 L m(-2), and SVR between 800 and 1200 dyn s(-1) cm(-5). When a vasopressor is necessary, vasopressin should be used as the drug of choice. If vasopressin is not available, noradrenaline or adrenaline may be used. Haemoglobin concentration should be maintained between 5.5-6.2 mmol L(-1). In a potential heart donor, troponin concentration should be checked daily. Neutral thermal conditions should be maintained using a warm air blower. A brain dead patient cannot maintain adequate pituitary function, therefore hormone replacement therapy with methylprednisolone, thyroxin and desmopressin is indicated. Glucose concentrations should be kept within the normal range, using insulin if necessary. The lung harvesting protocol should be similarto ARDS treatment guidelines (optimal PEEP, low tidal volumes). Lung recruitment manoeuvres, and aggressive prevention and treatment of nosocomial infection are essential.
authors.affiliation: 'Oddział Kliniczny Kardioanestezji i Intensywnej Terapii Slaskiego Uniwersytetu Medycznego, Slaskie Centrum Chorób Serca w Zabrzu. kardanest@sum.edu.pl
authors.forename: Ewa
authors.initials: E
authors.lastname: Kucewicz
authors.forename: Jacek
authors.initials: J
authors.lastname: Wojarski
authors.forename: Sławomir
authors.initials: S
authors.lastname: Zegleń
authors.forename: Wojciech
authors.initials: W
authors.lastname: Saucha
authors.forename: Tomasz
authors.initials: T
authors.lastname: Maciejewski
authors.forename: Jerzy
authors.initials: J
authors.lastname: Pacholewicz
authors.forename: Roman
authors.initials: R
authors.lastname: Przybylski
authors.forename: Piotr
authors.initials: P
authors.lastname: Knapik
authors.forename: Marian
authors.initials: M
authors.lastname: Zembala
mesh_terms: D002985:Clinical Protocols; D003428:Cross Infection / Q000517:prevention & control; D006334:Heart Function Tests; D020249:Hormone Replacement Therapy; D006801:Humans; D016040:Lung Transplantation / Q000379:methods; D016343:Monitoring, Intraoperative / Q000379:methods; D053717:Pneumonia, Ventilator-Associated / Q000517:prevention & control; D014019:Tissue Donors; D020858:Tissue and Organ Harvesting / Q000379:methods*